東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Microbiome in inflammatory lung diseases

Gupta, Gaurav.

Linked to FindBook

Google Book

Amazon

博客來

Microbiome in inflammatory lung diseases

Record Type:	Electronic resources : Monograph/item
Title/Author:	Microbiome in inflammatory lung diseases/ edited by Gaurav Gupta ... [et al.].
other author:	Gupta, Gaurav.
Published:	Singapore :Springer Singapore : : 2022.,
Description:	xii, 377 p. :ill., digital ;24 cm.
[NT 15003449]:	Introduction to Lung Diseases -- Introduction to Microbiome -- Role of Microbiome in Inflammation -- The interplay of microbiome, inflammation, and immunity in inflammatory lung diseases -- Microbiome in Asthma -- Microbiome in Chronic Obstructive Pulmonary Disease -- Microbiome in Asthma-COPD Overlap syndrome (ACO) -- Microbiome in ARDS (Acute Respiratory Distress Syndrome) -- Role of brain-gut- microbiome axis in Depression co-morbid with COPD or Asthma -- Microbiome in Lung Cancer -- Microbiome in Pulmonary Tuberculosis -- Lung Microbiome: Friend or Foe of Mycobacterium tuberculosis -- Microbiome in Idiopathic Pulmonary Fibrosis. Microbiome in SARS-Cov2 (Covid-19) -- Status of the microbiome in SARS-Cov2 (Covid-19) -- Microbiome in Influenza-A Virus Infection -- Microbiome in Upper Respiratory Tract Infection (URTI) -- Challenges in understanding the lung microbiota -- Microbiome in Inflammatory Lung Diseases: Challenges and Future Prospects -- Microbiota targeted via nanotechnology for lung cancer therapy: Challenges and future perspectives.
Contained By:	Springer Nature eBook
Subject:	Lungs - Diseases. -
Online resource:	https://doi.org/10.1007/978-981-16-8957-4
ISBN:	9789811689574

Microbiome in inflammatory lung diseases
Microbiome in inflammatory lung diseases[electronic resource] /edited by Gaurav Gupta ... [et al.]. - Singapore :Springer Singapore :2022. - xii, 377 p. :ill., digital ;24 cm.

Introduction to Lung Diseases -- Introduction to Microbiome -- Role of Microbiome in Inflammation -- The interplay of microbiome, inflammation, and immunity in inflammatory lung diseases -- Microbiome in Asthma -- Microbiome in Chronic Obstructive Pulmonary Disease -- Microbiome in Asthma-COPD Overlap syndrome (ACO) -- Microbiome in ARDS (Acute Respiratory Distress Syndrome) -- Role of brain-gut- microbiome axis in Depression co-morbid with COPD or Asthma -- Microbiome in Lung Cancer -- Microbiome in Pulmonary Tuberculosis -- Lung Microbiome: Friend or Foe of Mycobacterium tuberculosis -- Microbiome in Idiopathic Pulmonary Fibrosis. Microbiome in SARS-Cov2 (Covid-19) -- Status of the microbiome in SARS-Cov2 (Covid-19) -- Microbiome in Influenza-A Virus Infection -- Microbiome in Upper Respiratory Tract Infection (URTI) -- Challenges in understanding the lung microbiota -- Microbiome in Inflammatory Lung Diseases: Challenges and Future Prospects -- Microbiota targeted via nanotechnology for lung cancer therapy: Challenges and future perspectives.

This book reviews the role of the lung microbiome in the development and progression of lung diseases. It deals with the role of microbiota dysbiosis in influencing host defense and immunity leading to resistance, colonization, and disease exacerbation. The book delineates the complex interaction between pathogen and lung residual microbiota during disease conditions. It further highlights the potential role of lung microbiota as the key modulator of lung carcinogenesis and immune response against cancer cells. Lastly, it reviews technological developments for unraveling the lung microbiome that profoundly impacts clinical diagnostics. This book is an essential resource for the scientists working in pulmonary diseases, pharmaceutical & clinical sciences, and pulmonary clinicians.

ISBN: 9789811689574

Standard No.: 10.1007/978-981-16-8957-4doiSubjects--Topical Terms:

1006034
Lungs
--Diseases.

LC Class. No.: RC756 / .M53 2022

Dewey Class. No.: 616.24

Microbiome in inflammatory lung diseases
LDR:02841nmm a2200325 a 4500 001 2298086
003 DE-He213
005 20220325072550.0
006 m d
007 cr nn 008maaau
008 230324s2022 si s 0 eng d
020 $a 9789811689574 $q (electronic bk.)
020 $a 9789811689567 $q (paper)
024 7 $a 10.1007/978-981-16-8957-4 $2 doi
035 $a 978-981-16-8957-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC756 $b .M53 2022
072 7 $a PSG $2 bicssc
072 7 $a SCI045000 $2 bisacsh
072 7 $a PSG $2 thema
082 0 4 $a 616.24 $2 23
090 $a RC756 $b .M626 2022
245 0 0 $a Microbiome in inflammatory lung diseases $h [electronic resource] / $c edited by Gaurav Gupta ... [et al.].
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2022.
300 $a xii, 377 p. : $b ill., digital ; $c 24 cm.
505 0 $a Introduction to Lung Diseases -- Introduction to Microbiome -- Role of Microbiome in Inflammation -- The interplay of microbiome, inflammation, and immunity in inflammatory lung diseases -- Microbiome in Asthma -- Microbiome in Chronic Obstructive Pulmonary Disease -- Microbiome in Asthma-COPD Overlap syndrome (ACO) -- Microbiome in ARDS (Acute Respiratory Distress Syndrome) -- Role of brain-gut- microbiome axis in Depression co-morbid with COPD or Asthma -- Microbiome in Lung Cancer -- Microbiome in Pulmonary Tuberculosis -- Lung Microbiome: Friend or Foe of Mycobacterium tuberculosis -- Microbiome in Idiopathic Pulmonary Fibrosis. Microbiome in SARS-Cov2 (Covid-19) -- Status of the microbiome in SARS-Cov2 (Covid-19) -- Microbiome in Influenza-A Virus Infection -- Microbiome in Upper Respiratory Tract Infection (URTI) -- Challenges in understanding the lung microbiota -- Microbiome in Inflammatory Lung Diseases: Challenges and Future Prospects -- Microbiota targeted via nanotechnology for lung cancer therapy: Challenges and future perspectives.
520 $a This book reviews the role of the lung microbiome in the development and progression of lung diseases. It deals with the role of microbiota dysbiosis in influencing host defense and immunity leading to resistance, colonization, and disease exacerbation. The book delineates the complex interaction between pathogen and lung residual microbiota during disease conditions. It further highlights the potential role of lung microbiota as the key modulator of lung carcinogenesis and immune response against cancer cells. Lastly, it reviews technological developments for unraveling the lung microbiome that profoundly impacts clinical diagnostics. This book is an essential resource for the scientists working in pulmonary diseases, pharmaceutical & clinical sciences, and pulmonary clinicians.
650 0 $a Lungs $x Diseases. $3 1006034
650 0 $a Inflammation $x Immunological aspects. $3 895504
650 0 $a Microorganisms. $3 666946
650 0 $a Medical microbiology. $3 571470
650 1 4 $a Microbial Communities. $3 3531327
650 2 4 $a Inflammation. $3 662994
650 2 4 $a Respiratory Physiology. $3 773580
650 2 4 $a Cancer Biology. $3 3594253
700 1 $a Gupta, Gaurav. $3 1044694
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-16-8957-4
950 $a Biomedical and Life Sciences (SpringerNature-11642)